NCT03418948 (EXCEED) is a NA clinical trial of CC followed by EC in Colorectal Neoplasms, sponsored by Radboud University Medical Center.

Who is sponsoring NCT03418948?

NCT03418948 is sponsored by Radboud University Medical Center.

What drugs are being tested in NCT03418948?

Interventions in NCT03418948: CC followed by EC, EC followed by CC, 2x EC, 2x CC.

What condition does NCT03418948 study?

NCT03418948 studies Colorectal Neoplasms.

Is NCT03418948 still recruiting?

NCT03418948 is currently status unknown. Last updated 1 February 2018.

Last reviewed 2018-02-01 · How we verify

NCT03418948: EXCEED

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of AMR and ADR Between Endocuff Vision-assisted and Conventional Colonoscopy: a Multicenter Randomized Trial

Status unknown NA Last updated 1 February 2018

What this trial tests

NA trial testing CC followed by EC in Colorectal Neoplasms in 708 participants. Status unknown.

Timeline

8 December 2017

Primary endpoint
1 September 2019

1 November 2019

Quick facts

Lead sponsor	Radboud University Medical Center
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	diagnostic
Enrollment	708
Start date	8 December 2017
Primary completion	1 September 2019
Estimated completion	1 November 2019
Sites	3 locations across Netherlands, Greece

Drugs / interventions tested

CC followed by EC
EC followed by CC
2x EC
2x CC

Conditions studied

Colorectal Neoplasms — all drugs for Colorectal Neoplasms →

Sponsor

Radboud University Medical Center

Who can join

Adults 40 to 75, any sex, with Colorectal Neoplasms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this international multicenter study is to compare the adenoma detection rate and adenoma miss rate of conventional and Endocuff Vision-assisted colonoscopy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Comparison of adenoma miss rate and adenoma detection rate between conventional colonoscopy and colonoscopy with second-generation distal attachment cuff: a multicenter, randomized, back-to-back trial.
van Keulen KE, Papanikolaou IS, Mak TWC, Apostolopoulos P, et al · · 2024 · cited 9× · PMID 37993062 · DOI 10.1016/j.gie.2023.11.017

Verify or expand the search:

Other recruiting trials for Colorectal Neoplasms

Currently open trials in the same condition.

NCT06983639 — Randomized Trial Comparing Fecal Testing (FIT) to Colonoscopy for Post-polypectomy Surveillance · NA · recruiting
NCT07222800 — Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult · Phase 3 · recruiting
NCT07239479 — DEXDES Trial: Dexmedetomidine-Desflurane Combination in Laparoscopic Colectomy · NA · recruiting
NCT07262840 — Health Behavior Change in High-Risk Colorectal Cancer Individuals · NA · recruiting
NCT07257653 — The Safety and Efficacy of Cetuximab Beta Plus Fruquintinib With or Without Immune Checkpoint Inhibitorrs in First-line · Phase 2 · recruiting

Other Radboud University Medical Center trials

Trials by the same sponsor.

NCT07485569 — Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial · Phase 1 · not yet recruiting
NCT07514325 — MR-guided Adaptive Stereotactic Radiotherapy for Endometrial Cancer · NA · not yet recruiting
NCT07530263 — Deposition of Inhaled Liposomal Amphotericin B in Chronic Pulmonary Aspergillosis (CPA) · Phase 1 · not yet recruiting
NCT07532577 — Intranasal Insulin to Prevent Intensive Care Unit Delirium · Phase 2, PHASE3 · not yet recruiting
NCT07504172 — Real-world Effectiveness and Dosing Patterns of Tirzepatide in People With Obesity · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03418948 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Radboud University Medical Center
Last refreshed: 1 February 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03418948.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing